Log in

9600 Qomel Company TADAWUL · Saudi Arabia

Qomel (9600) news

Qomel Company is a public biotech or pharmaceutical company listed on TADAWUL under the ticker 9600, recorded under Saudi Arabia. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Qomel news

We have not published a story on Qomel yet. When there is news, it will appear here.

Questions about Qomel

What is the ticker symbol of Qomel?

Qomel Company trades under the ticker 9600 on TADAWUL.

Where is Qomel listed?

Qomel Company is listed on TADAWUL.

Which country or territory is Qomel listed under?

Our directory records Qomel Company under Saudi Arabia.

What does Qomel do?

Our directory classifies Qomel Company as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Qomel?

The ISIN recorded for Qomel Company is SA162184M018.

Does aibio.space cover Qomel?

aibio.space lists Qomel Company among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Qomel?

Companies in our directory listed in the same country and business area as Qomel: Middle East Pharmaceutical Industries, Saudi Pharmaceutical Industries & Medical Appliances, Jamjoom Pharmaceuticals Factory Co., Astra Industrial Group.

Investor discussion: Qomel

Members talk about Qomel (9600). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open TADAWUL:9600 on TradingView.

Listing details

Qomel Company is a public biotech or pharmaceutical company listed on TADAWUL under the ticker 9600, recorded under Saudi Arabia. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Qomel Company
Ticker
9600
Listing
TADAWUL
Country or territory
Saudi Arabia
Business scope
Pharmaceuticals: Major
ISIN
SA162184M018
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.